- Home
- / VCANBIO
VCANBIO
Stock Price
¥21.3
2024-10-29
Market Capitalization
¥10.1 B
2024-10-29
Revenue
¥1.4 B
FY, 2025
VCANBIO Summary
Company Summary
- Overview
- VCANBIO Cell & Gene Engineering (also known as Zhongyuan Union) is a biotech company that offers health management services and products. It provides precise prevention, accurate diagnosis, and cell therapy solutions.
- Type
- Public
- Status
- Active
- Founded
- 1993
- HQ
- Tianjin, CN | view all locations
- Website
- https://www.vcanbio.com/
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
1 location detected
Tianjin, Tianjin HQ
China
No. 12, Meiyuan Road, Huayuan Industrial Zone, Binhai High-tech Zone
VCANBIO Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥312.0M
- Gross profit (Q1, 2026)
- ¥215.4M
- Net income (Q1, 2026)
- ¥24.2M
- Cash (Q1, 2026)
- ¥1.6B
- EBIT (Q1, 2026)
- ¥33.4M
- Enterprise value
- $8.6B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026